{"news_desk": "Business", "print_page": "1", "section_name": "Business Day", "subsection_name": null, "document_type": "article", "multimedia": [{"height": 126, "subtype": "wide", "legacy": {"widewidth": "190", "wide": "images/2015/01/10/business/10ear-web1/10ear-web1-thumbWide-v2.jpg", "wideheight": "126"}, "type": "image", "width": 190, "url": "images/2015/01/10/business/10ear-web1/10ear-web1-thumbWide-v2.jpg"}, {"height": 411, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "411", "xlarge": "images/2015/01/10/business/10ear-web1/10ear-web1-articleLarge-v2.jpg"}, "type": "image", "width": 600, "url": "images/2015/01/10/business/10ear-web1/10ear-web1-articleLarge-v2.jpg"}, {"height": 75, "subtype": "thumbnail", "legacy": {"thumbnail": "images/2015/01/10/business/10ear-web1/10ear-web1-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "type": "image", "width": 75, "url": "images/2015/01/10/business/10ear-web1/10ear-web1-thumbStandard.jpg"}], "abstract": "Large pharmaceutical companies and start-ups are trying to come up with treatments for ear disorders, area of study that has been largely ignored, despite huge need; ear treatments are difficult to develop, mainly due to the complexity of the ear anatomy, but potential financial gains are driving research.", "type_of_material": "News", "word_count": "1501", "lead_paragraph": "In search of an alternative to hearing aids or implants, some report success in early trials for drugs to improve hearing or silence tinnitus.", "pub_date": "2015-01-10T00:00:00Z", "_id": "54b03abd38f0d8367c8413c1", "byline": {"contributor": "", "original": "By ANDREW POLLACK", "person": [{"rank": 1, "role": "reported", "firstname": "Andrew", "organization": "", "lastname": "POLLACK"}]}, "source": "The New York Times", "snippet": "In search of an alternative to hearing aids or implants, some report success in early trials for drugs to improve hearing or silence tinnitus.", "web_url": "http://www.nytimes.com/2015/01/10/business/ear-disorders-long-neglected-attract-drug-makers-attention-.html", "slideshow_credits": null, "blog": [], "keywords": [{"rank": "1", "is_major": "Y", "value": "Ears and Hearing", "name": "subject"}, {"rank": "11", "is_major": "N", "value": "GlaxoSmithKline PLC", "name": "organizations"}, {"rank": "12", "is_major": "N", "value": "Avalon Ventures Limited", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Otonomy Inc.", "name": "organizations"}, {"rank": "4", "is_major": "N", "value": "Auris Medical Holding A.G.", "name": "organizations"}, {"rank": "5", "is_major": "N", "value": "Novartis AG", "name": "organizations"}, {"rank": "6", "is_major": "N", "value": "Clinical Trials", "name": "subject"}, {"rank": "7", "is_major": "N", "value": "Start-ups", "name": "subject"}, {"rank": "8", "is_major": "N", "value": "Tinnitus", "name": "subject"}, {"rank": "9", "is_major": "N", "value": "Pfizer Inc", "name": "organizations"}, {"rank": "10", "is_major": "N", "value": "Roche Holding AG", "name": "organizations"}], "headline": {"main": "From Vertigo to Tinnitus, Ear Ailments Are New Focus for Drugs  ", "print_headline": "Music to the Ears"}}